The pharmaceutical and healthcare sector is defined by complex regulatory and intellectual property

 constraints. Patent protection marketing authorisation clinical data and distribution frameworks are closely

 interconnected and every legal decision has direct implications on exclusivity market access and long term

commercial viability.